Literature DB >> 15849761

Prevalence and risk factors for heart disease among males with hemophilia.

Roshni Kulkarni1, J Michael Soucie, Bruce L Evatt.   

Abstract

There have been conflicting reports in the literature about the protective effect of hemophilia on the occurrence of ischemic heart disease (IHD). Circulatory disease has been reported as the second most common cause of death in persons with hemophilia in the United States. In addition to diabetes and hypertension, high levels of FVIII, as may occur during factor concentrate infusions, may increase IHD risk in this population. To estimate the prevalence of heart disease and examine factors associated with IHD and other heart diseases among persons with hemophilia, we analyzed data collected from the medical records of 3,422 males with hemophilia living in six U.S. states from 1993 to 1998. Heart disease cases were ascertained from among 2,075 persons who were hospitalized at least once during the 6-year period. Of these, 48 were diagnosed with IHD and 106, with other types of heart disease. The age-specific prevalence of IHD ranged from 0.05% in those under 30 years to 15.2% in those 60 years or older. Hospital discharge rates in males with hemophilia with IHD and other types of heart disease were lower compared to rates in age-matched U.S. males. In our cohort, as in the general population, IHD was independently associated with age, hypertension, diabetes, and hyperlipidemia. Other heart diseases were associated with HIV infection, hypertension, hemophilia B, and diabetes. In summary, persons with hemophilia have unique risk factors such as infusion of factor concentrates and infection with HIV that may predispose them to heart disease as their life expectancy increases. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15849761     DOI: 10.1002/ajh.20339

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  15 in total

1.  Public health surveillance and data collection: general principles and impact on hemophilia care.

Authors:  J Michael Soucie
Journal:  Hematology       Date:  2012-04       Impact factor: 2.269

2.  Coronary atherosclerosis and cardiovascular mortality in hemophilia.

Authors:  C J Foley; L Nichols; K Jeong; C G Moore; M V Ragni
Journal:  J Thromb Haemost       Date:  2009-10-26       Impact factor: 5.824

3.  Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia A.

Authors:  M V Ragni; C G Moore
Journal:  Haemophilia       Date:  2011-03-04       Impact factor: 4.287

Review 4.  How I treat patients with inherited bleeding disorders who need anticoagulant therapy.

Authors:  Karlyn Martin; Nigel S Key
Journal:  Blood       Date:  2016-04-22       Impact factor: 22.113

5.  Recombinant factor VIII in the management of hemophilia A: current use and future promise.

Authors:  Jerry S Powell
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

6.  Public health surveillance of nonmalignant blood disorders.

Authors:  Michele G Beckman; Mary M Hulihan; Vanessa R Byams; Meredith A Oakley; Nimia Reyes; Sean Trimble; Althea M Grant
Journal:  Am J Prev Med       Date:  2014-09-19       Impact factor: 5.043

7.  Risk factors for cardiovascular disease in children and young adults with haemophilia.

Authors:  Jacqueline Limjoco; Courtney D Thornburg
Journal:  Haemophilia       Date:  2018-07-13       Impact factor: 4.287

8.  A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Authors:  Suman L Sood; Dunlei Cheng; Margaret Ragni; Craig M Kessler; Doris Quon; Amy D Shapiro; Nigel S Key; Marilyn J Manco-Johnson; Adam Cuker; Christine Kempton; Tzu-Fei Wang; M Elaine Eyster; Philip Kuriakose; Annette von Drygalski; Joan Cox Gill; Allison Wheeler; Peter Kouides; Miguel A Escobar; Cindy Leissinger; Sarah Galdzicka; Marshall Corson; Crystal Watson; Barbara A Konkle
Journal:  Blood Adv       Date:  2018-06-12

9.  Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care.

Authors:  Aroub A Khleif; Nidra Rodriguez; Deborah Brown; Miguel A Escobar
Journal:  J Aging Res       Date:  2011-09-07

10.  Cognitive and psychological profiles in treatment compliance: a study in an elderly population with hemophilia.

Authors:  Silvia Riva; Alessandro Nobili; Codjo D Djade; Maria Elisa Mancuso; Elena Santagostino; Gabriella Pravettoni
Journal:  Clin Interv Aging       Date:  2015-07-09       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.